Literature DB >> 25386057

Hypoxia and fatty liver.

Tomohiro Suzuki1, Satoko Shinjo1, Takatomo Arai1, Mai Kanai1, Nobuhito Goda1.   

Abstract

The liver is a central organ that metabolizes excessive nutrients for storage in the form of glycogen and lipids and supplies energy-producing substrates to the peripheral tissues to maintain their function, even under starved conditions. These processes require a considerable amount of oxygen, which causes a steep oxygen gradient throughout the hepatic lobules. Alcohol consumption and/or excessive food intake can alter the hepatic metabolic balance drastically, which can precipitate fatty liver disease, a major cause of chronic liver diseases worldwide, ranging from simple steatosis, through steatohepatitis and hepatic fibrosis, to liver cirrhosis. Altered hepatic metabolism and tissue remodeling in fatty liver disease further disrupt hepatic oxygen homeostasis, resulting in severe liver hypoxia. As master regulators of adaptive responses to hypoxic stress, hypoxia-inducible factors (HIFs) modulate various cellular and organ functions, including erythropoiesis, angiogenesis, metabolic demand, and cell survival, by activating their target genes during fetal development and also in many disease conditions such as cancer, heart failure, and diabetes. In the past decade, it has become clear that HIFs serve as key factors in the regulation of lipid metabolism and fatty liver formation. This review discusses the molecular mechanisms by which hypoxia and HIFs regulate lipid metabolism in the development and progression of fatty liver disease.

Entities:  

Keywords:  Fatty liver disease; Hypoxia; Hypoxia-inducible factor; Lipid metabolism; Obstructive sleep apnea

Mesh:

Substances:

Year:  2014        PMID: 25386057      PMCID: PMC4223242          DOI: 10.3748/wjg.v20.i41.15087

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  125 in total

Review 1.  Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance.

Authors:  David B Savage; Robert K Semple
Journal:  Curr Opin Lipidol       Date:  2010-08       Impact factor: 4.776

2.  Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome.

Authors:  H Gastaut; C A Tassinari; B Duron
Journal:  Brain Res       Date:  1966-02       Impact factor: 3.252

3.  Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

Authors:  V H Haase; J N Glickman; M Socolovsky; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

4.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

Authors:  Kimihiko Matsusue; Martin Haluzik; Gilles Lambert; Sun-Hee Yim; Oksana Gavrilova; Jerrold M Ward; Bryan Brewer; Marc L Reitman; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

5.  Selective inhibition of hypoxia-inducible factor 1α ameliorates adipose tissue dysfunction.

Authors:  Kai Sun; Nils Halberg; Mahmood Khan; Ulysses J Magalang; Philipp E Scherer
Journal:  Mol Cell Biol       Date:  2012-12-17       Impact factor: 4.272

Review 6.  Mitochondrial complex III regulates hypoxic activation of HIF.

Authors:  T Klimova; N S Chandel
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

7.  Chronic intermittent hypoxia predisposes to liver injury.

Authors:  Vladimir Savransky; Ashika Nanayakkara; Angelica Vivero; Jianguo Li; Shannon Bevans; Philip L Smith; Michael S Torbenson; Vsevolod Y Polotsky
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

Review 8.  Molecular mechanisms of alcoholic fatty liver.

Authors:  Vishnudutt Purohit; Bin Gao; Byoung-Joon Song
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

9.  Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo.

Authors:  G E Arteel; Y Iimuro; M Yin; J A Raleigh; R G Thurman
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

10.  Carbohydrate-responsive element-binding protein (ChREBP) is a negative regulator of ARNT/HIF-1beta gene expression in pancreatic islet beta-cells.

Authors:  Nafeesa A Noordeen; Tarnjit K Khera; Gao Sun; E Rebecca Longbottom; Timothy J Pullen; Gabriela da Silva Xavier; Guy A Rutter; Isabelle Leclerc
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more
  29 in total

1.  Translational and transcriptional responses in human primary hepatocytes under hypoxia.

Authors:  Gaya K Hettiarachchi; Upendra K Katneni; Ryan C Hunt; Jacob M Kames; John C Athey; Haim Bar; Zuben E Sauna; Joseph R McGill; Juan C Ibla; Chava Kimchi-Sarfaty
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

Review 2.  Obstructive Sleep Apnea and the Liver.

Authors:  Malav P Parikh; Niyati M Gupta; Arthur J McCullough
Journal:  Clin Liver Dis       Date:  2019-05       Impact factor: 6.126

3.  The Impact of Intermittent Hypobaric Hypoxia Exposures on Triacylglycerol Synthesis in Rat Liver.

Authors:  Syarifah Dewi; Yulhasri Yulhasri; Wawan Mulyawan
Journal:  Rep Biochem Mol Biol       Date:  2021-10

Review 4.  Hypoxic/Ischemic Inflammation, MicroRNAs and δ-Opioid Receptors: Hypoxia/Ischemia-Sensitive Versus-Insensitive Organs.

Authors:  Yimeng Chen; Yichen He; Shuchen Zhao; Xiaozhou He; Dong Xue; Ying Xia
Journal:  Front Aging Neurosci       Date:  2022-05-09       Impact factor: 5.702

Review 5.  Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.

Authors:  Sander Lefere; Christophe Van Steenkiste; Xavier Verhelst; Hans Van Vlierberghe; Lindsey Devisscher; Anja Geerts
Journal:  Cell Mol Life Sci       Date:  2016-04-18       Impact factor: 9.261

6.  Post-mortem analysis of lactate concentration in diabetics and metformin poisonings.

Authors:  T Keltanen; T Nenonen; R A Ketola; I Ojanperä; A Sajantila; K Lindroos
Journal:  Int J Legal Med       Date:  2015-09-01       Impact factor: 2.686

7.  Hepatocyte HIF-1 and Intermittent Hypoxia Independently Impact Liver Fibrosis in Murine Nonalcoholic Fatty Liver Disease.

Authors:  Omar A Mesarwi; Esteban A Moya; Xin Zhen; Mary Gautane; Huyai Zhao; Paula Wegbrans Giró; Mouza Alshebli; Kendall E McCarley; Ellen C Breen; Atul Malhotra
Journal:  Am J Respir Cell Mol Biol       Date:  2021-10       Impact factor: 6.914

8.  Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease.

Authors:  Omar A Mesarwi; Mi-Kyung Shin; Shannon Bevans-Fonti; Christina Schlesinger; Janet Shaw; Vsevolod Y Polotsky
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

9.  Different Expressions of HIF-1α and Metabolism in Brain and Major Visceral Organs of Acute Hypoxic Mice.

Authors:  Lu Xu; Hua Song; Qi Qiu; Ting Jiang; Pingyun Ge; Zaiji Su; Wenhui Ma; Ran Zhang; Caihua Huang; Shanhua Li; Donghai Lin; Jiaxing Zhang
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

Review 10.  Hypoxia-inducible factors as molecular targets for liver diseases.

Authors:  Cynthia Ju; Sean P Colgan; Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2016-04-20       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.